Call Us08045479576
Salbutamol Sulfate

Salbutamol Sulfate

8000 INR/Kilograms

Product Details:

  • Taste Other
  • Ph Level 3.510
  • Molecular Weight 576.70 Grams (g)
  • Smell No Smell
  • Structural Formula C26H44N2O10S
  • Loss on Drying 0.32 %
  • Shelf Life 1 Years
  • Click to View more
X

Salbutamol Sulfate Price And Quantity

  • 8000.00 - 9000.00 INR/Kilograms
  • 8000 INR/Kilograms
  • 25 Kilograms

Salbutamol Sulfate Product Specifications

  • C26H44N2O10S
  • No Smell
  • 576.70 Grams (g)
  • Pharmaceutical Intermediates
  • 180
  • 98%
  • Room Temperature
  • 3.510
  • 576.70
  • 51022-70-9
  • 29051420
  • 433.5 at 760 mmHg
  • Medicine Grade
  • Other
  • 256-916-8
  • Salbutamol is a drug used in the treatment of asthma, a chronic lung disease caused by inflammation of the lower airways.
  • 1 Years
  • Freely soluble in water, practically insoluble or very slightly soluble in ethanol (96 %) and in methylene chloride. It shows polymorphism
  • white crystalline solid
  • alpha.1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-.alpha., .alpha.-diol sulfate (2:1) salt;Bronchospray;(+-)-Salbutamol sulfate;Albuterol sulfate (USP);1-(4-Hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol sulfate;Loftan;Epaq;1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2:1) (salt) (9CI);Ventolin HFA;Emican;Salbutamol hemisulfate;Broncho Inhalat;Huma-Salmol;Albuterol sulfate / Salbutamol sulfate;
  • SALBUTAMOL SULPHATE
  • Powder
  • 0.32 %

Salbutamol Sulfate Trade Information

  • Letter of Credit (L/C) Cash Against Delivery (CAD) Telegraphic Transfer (T/T) Cash in Advance (CID) Cash Advance (CA)
  • 1000 Kilograms Per Day
  • 7 Days
  • Free samples are available
  • DRUM
  • Western Europe Middle East Central America South America Asia Eastern Europe North America Australia Africa
  • ISO, GMP

Product Description

Salbutamol Sulfate provided by us, is designed and manufactured by making use of premium grade of raw materials and upgraded technology. This sulfate obstructive pulmonary disease (COPD) such as coughing, wheezing and feeling breathless. This is clinically tested under various parameters to ensure its effectiveness and high performance. It is used to relieve symptoms of asthma and chronic diseases. This Sulphate is very cost effective and can be easily purchased by our eminent customers, at nominal pricing, in bulk quantities.

Salbutamol Sulfate Properties:

  • CAS Number: 51022-70-9
  • Formula: 2(C13H21NO3).H2O4S
  • Molecular Weight: 576.70
  • Deleted CAS: 36519-31-0
  • Synonyms: .alpha.1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-.alpha., .alpha.-diol sulfate (2: 1) salt;Bronchospray;(+-)-Salbutamol sulfate;Albuterol sulfate (USP); Ventolin HFA;Emican;Salbutamol hemisulfate;Broncho Inhalat;Huma-Salmol;Albuterol sulfate / Salbutamol sulfate; 1-(4-Hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol sulfate;Loftan;Epaq;1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2: 1) (salt) (9CI);
  • EINECS: 256-916-8
  • Melting Point: 180 degree centigrade
  • Boiling Point: 433.5 degree centigrade at 760 mmHg
  • Flash Point: 159.5 degree centigrade
  • Solubility: Soluble in water
  • Appearance: White crystalline solid

How does it work


Asthma and chronic obstructive pulmonary disease (COPD) are treated with salbutamol to relieve symptoms in breathing, coughing, and wheezing. Breathing becomes easier when the muscles in the airways to the lungs are relaxed. The inhaler (puffer) contains salbutamol.

Applications Or where it is used


The medication is often prescribed for bronchospasm (resulting from allergic asthma or exercise-induced bronchospasm) and chronic obstructive pulmonary disease. The medicine is also widely used in rescue inhalers (short-term bronchodilators that relieve asthma attacks).

Manufacturing process


The process comprises following steps:  

1. Chloromethylation reaction: Compound 1 is generated when p-hydroxy benzaldehyde and paraformaldehyde reacts under an acidic condition. 
2. Hydrolysis reaction: Compound 1 undergoes hydrolysis under alkaline conditions to give compound.

How to use


You should inhale the prescribed medications into your lungs using a mouthpiece or mask as directed by your doctor, usually 3 or 4 times daily as needed. Treatments usually take between five and fifteen minutes each. Only use a nebulizer to administer this medication. The solution should not be swallowed or injected.

Dosage of usage


There are different doses for different patients. Take the medication exactly as directed by your doctor. Until your doctor instructs you otherwise, do not change your dose if it is different. Amount of medicine you take depends on how strong it is. You also have to take medicine according to the medical problem you are treating. This includes how many doses per day, how long you should wait between doses, and the length of time you should remain on the medicine.

Side Effects


Below are few side effects:
  • Headache
  • Feeling nervous, restless, excitable and/or shaky
  • Uneven heartbeat
  • Bad taste
  • Dry mouth
  • Sore throat and cough
  • Inability to sleep

Warnings and precautions while using Salbutamol Sulphate


You may notice that your wheezing or breathing will worsen because of paradoxical bronchospasm caused by this medicine. It could be fatal. When you or your child cough, have trouble breathing, shortness of breath, or wheeze after using this medicine, contact your doctor immediately.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category